LBO France, a multi-specialist investment platform and pioneer in private equity, announced today the signing of a definitive ...

Eli Lilly has signed its second pipeline-building deal in two days, reaching an agreement to buy in vivo CAR-T developer Orna ...

The restaurant, located in the former Carrabba’s Italian Grill at 5110 Poplar Ave., officially opens with a ribbon-cutting ...

Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion ...

Vivo continues to lead India’s smartphone market with a 20% volume share in Q4 2025, followed by Samsung and Oppo, noted ...

It's the latest in a string of science-focused deals that the pharmaceutical giant has made over the past 12 months as its ...

The UK-based AI-compute power service provider VivoPower is changing its digital asset exposure after agreeing to transfer ...

Android remains the top choice for India’s mass-market smartphone users despite the increasing popularity of the iPhone.

East Memphis is about to get a lot hotter. Fuego Vivo, a new high-heat concept from Tekila Group, is slated to open in mid-February at 5110 Poplar Avenue, taking over the former Carrabba's space.

As its GLP-1 rival goes after compounders, Eli Lilly and Co. started the week with news beyond its diabetes and obesity franchise. The company, which disclosed a new agreement with Innovent Biologics ...

The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical ...

Eli Lilly announced an acquisition of an innovative new autoimmune drug.